Eli Lilly and Co (LLY)
110.69
+0.21 +0.19%
NYSE
Oct 15, 16:58
Delayed 2m
USD
View All Key Stats
LLY Key Stats
| Income Statement | |
| Revenue (TTM) | 23.87B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.13 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -143.80M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 73.21% |
| Profit Margin (Quarterly) | -4.09% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 118.88B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.845 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 10.29 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -340.70M |
| Return on Equity (TTM) | Upgrade |
View All LLY News
LLY News
-
WireHeadlineTime (ET)
-
SA Breaking News10/15 15:26
-
Yahoo10/15 14:20
-
SA Breaking News10/15 14:01
-
PR Newswire10/15 13:57
-
Yahoo10/15 12:09
-
Yahoo10/15 11:23
-
Yahoo10/15 11:16
-
Yahoo10/15 11:10
-
Yahoo10/15 08:08
-
SA Breaking News10/15 07:30
View All Events
LLY Events
| Date | Type | Description |
|---|---|---|
| 01/31/2019 09:00 EST | Misc | Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2018 |
| 01/31/2019 | Earnings | Eli Lilly and Co Fourth Quarter Earnings in 2018 Release |
| 11/06/2018 08:00 EST | Misc | Eli Lilly and Co Third Quarter Earnings Conference Call in 2018 |
| 11/06/2018 | Earnings | Eli Lilly and Co Third Quarter Earnings Results in 2018 |
| 08/14/2018 | Dividends | Amount: 0.5625, Declared Date: Jun 18 2018, Pay Date: Sep 10 2018 |
| 07/24/2018 09:00 EDT | Misc | Eli Lilly and Co Second Quarter Earnings Conference Call in 2018 |
| 07/24/2018 | Earnings | Eli Lilly and Co Second Quarter Earnings Results in 2018 |
| 05/16/2018 | Dividends | Amount: 0.5625, Declared Date: May 08 2018, Pay Date: Jun 08 2018 |
| 05/07/2018 | Misc | Eli Lilly and Co Annual General Meeting in 2017 |
| 04/24/2018 09:00 EDT | Misc | Eli Lilly and Co First Quarter Earnings Conference Call in 2018 |
LLY Fundamentals
Income Statement View Statement
LLY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
LLY One Page Reports
- One Page Report Download
LLY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 110.69 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.lilly.com
- Investor Relations URL: https://investor.lilly.com/
- HQ State/Province: Indiana
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Nov. 06, 2018
- Last Earnings Release: Jul. 24, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 14, 2018
- Description: Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
LLY Excel Add-In Codes
- Name: =YCI("LLY","name")
- Description: =YCI("LLY","description")
- Sector: =YCI("LLY","sector")
- Industry: =YCI("LLY","industry")
- Est. Current Fiscal Year End: =YCI("LLY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other LLY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LLY Tweets Stocktwits
Advertisement
